|
Tecentriq (atezolizumab): a new important identified risk: immune-related myositis
|
|
Eurespal (fenspiride) withdrawal from the market in Armenia
|
|
Medicinal products containing carbimazole or thiamazole (methimazole): risk of acute pancreatitis and risks during pregnancy
|
|
Kadcyla: HCP Educational Information
|
|
Information about Flemoxin Solutab® (Amoxicillin trihydrate), Flemoclave Solutab® (Amoxicillin+clavulanic acid), Wilprafen Solutab® (Josamycin propionate), Suprax Solutab® (Cefixime), Unidox Solutab® (Doxycycline)
|
|
Actemra (tocilizumab)
|
|
Important safety update of prescribing information for xeloda® (capecitabine)
|
|
Information on Actemra
|
|
Eligard (leuprorelin acetate) - Medication errors associated with leakage due to overtightening of the safety needle
|
|
CELLCEPT (mycophenolate mofetil): risk of teratogenicity guide
|
